NP93420 Rituximab Subcut
A Voluntary Ex-Ante Transparency (VEAT) Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- not specified
- Value
- £2M
- Sector
- HEALTH
- Published
- 01 May 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Roche Products Welwyn Garden City
Description
Supply of Rituximab Subcut (Mabthera®) to NHS Scotland.
Total Quantity or Scope
The Framework Agreement is for the supply of Rituximab Subcut to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
1 | Roche Products (Welwyn Garden City)
|
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
Legal Justification
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015
Other Information
The estimated value of the Framework Agreement referred to in Section V.2.4 covers the nine (9) month duration of the proposed modification period of the Framework Agreement. NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=765324. (SC Ref:765324)
Reference
- FTS 014050-2024